Journal of Leukemia & Lymphoma

Items 1-5 of 14
«Preious | of 3 | Next»
1

Discontinuation of tyrosine kinase inhibitor therapy: can chronic myeloid leukemia be cured?

Journal of Leukemia & Lymphoma, Volume 21, Issue 03,2012, Pages 129-132, Dol:10.3760/cma.j.issn.1009-9921.2012.03.001

2

Influence of serum complement and IgG on rituximab-dependent NK cell-mediated cytotoxicity to Raji cells

Journal of Leukemia & Lymphoma, Volume 21, Issue 03,2012, Pages 133-136, Dol:10.3760/cma.j.issn.1009-9921.2012.03.002

3

Outcome of autologous peripheral blood stem cell transplantation for T cell lymphoma

Journal of Leukemia & Lymphoma, Volume 21, Issue 03,2012, Pages 137-140, Dol:10.3760/cma.j.issn.1009-9921.2012.03.003

4

A20 and TNF genes aberration in ocular adnexal MALT lymphomas

Journal of Leukemia & Lymphoma, Volume 21, Issue 03,2012, Pages 141-144, Dol:10.3760/cma.j.issn.1009-9921.2012.03.004

5

Significance of serum CD25/serum ferritin in the diagnosis of lymphoma-associated hemophagocytic syndrome

Journal of Leukemia & Lymphoma, Volume 21, Issue 03,2012, Pages 145-148, Dol:10.3760/cma.j.issn.1009-9921.2012.03.005

Items 1-5 of 14
«Preious | of 3 | Next»
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn